Literature DB >> 12074569

Involvement of CCAAT/enhancer-binding protein alpha in haptoglobin gene expression by all-trans-retinoic acid.

Il-Ha Lee1, Jeong-Hwa Lee, Myung-Jae Lee, Soo-Young Lee, In-Sook Kim.   

Abstract

Several acute-phase plasma proteins, including haptoglobin (Hp), are induced in the liver in response to inflammation. Recently, we found that Hp gene expression is up-regulated by all-trans-retinoic acid (ATRA) in the extrahepatic monocytic cell line, THP-1. To investigate the molecular mechanism underlying ATRA-induced Hp gene expression, we analyzed the induction of transcription factor CCAAT/enhancer-binding protein (C/EBP) isoforms in ATRA-stimulated THP-1 cells and their binding to the Hp promoter. Western blot analysis showed that treatment with ATRA increased C/EBPalpha and beta expression, but decreased that of C/EBPdelta. Electrophoretic mobility shift and supershift assays demonstrated that only C/EBPalpha of the C/EBP isoforms bound to the C/EBP DNA-binding sites in the Hp promoter. Furthermore, when ATRA-dependent Hp induction was inhibited by sodium butyrate or auranofin, induction of C/EBPalpha, but not C/EBPbeta, was also diminished. These results suggest that C/EBPalpha is involved in the activation of Hp gene expression by ATRA in human monocytic cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12074569     DOI: 10.1016/S0006-291X(02)00581-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Mechanisms regulating repression of haptoglobin production by peroxisome proliferator-activated receptor-gamma ligands in adipocytes.

Authors:  Cecile Vernochet; Kathryn E Davis; Philipp E Scherer; Stephen R Farmer
Journal:  Endocrinology       Date:  2009-12-01       Impact factor: 4.736

2.  MicroRNA expression in human retinal pigment epithelial (ARPE-19) cells: increased expression of microRNA-9 by N-(4-hydroxyphenyl)retinamide.

Authors:  R Krishnan Kutty; William Samuel; Cynthia Jaworski; Todd Duncan; Chandrasekharam N Nagineni; Nalini Raghavachari; Barbara Wiggert; T Michael Redmond
Journal:  Mol Vis       Date:  2010-08-04       Impact factor: 2.367

3.  Differentiation therapy of acute myeloid leukemia.

Authors:  Elzbieta Gocek; Ewa Marcinkowska
Journal:  Cancers (Basel)       Date:  2011-05-16       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.